After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Price with disclosed trades

Daily closes, past year · marks sit on transaction dates, sized by value

7 trades

Disclosure transactions for Prime Medicine
Reporting person Filed Transaction Transaction value Source Actions
Nelsen Robert Director / Ten Percent Owner Jun 8, 2026 3-day lag Award Jun 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Cahill Thomas Director Jun 8, 2026 3-day lag Award Jun 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Schenkein David P Director Jun 8, 2026 3-day lag Award Jun 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Foster-cheek Kaye I Director Jun 8, 2026 3-day lag Award Jun 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Kelly Michael Aaron Director Jun 8, 2026 3-day lag Award Jun 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Marrazzo Jeffrey D Director Jun 8, 2026 3-day lag Award Jun 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Chung Wendy Director Jun 8, 2026 3-day lag Award Jun 5, 2026 $0 Filed shares x price SEC Form 4 View filing
Nelsen Robert Director / Ten Percent Owner
Award
Calculated transaction value
$0 75,000 shares @ $0
Traded
Jun 5, 2026
Filed
Jun 8, 2026
Cahill Thomas Director
Award
Calculated transaction value
$0 75,000 shares @ $0
Traded
Jun 5, 2026
Filed
Jun 8, 2026
Schenkein David P Director
Award
Calculated transaction value
$0 75,000 shares @ $0
Traded
Jun 5, 2026
Filed
Jun 8, 2026
Foster-cheek Kaye I Director
Award
Calculated transaction value
$0 75,000 shares @ $0
Traded
Jun 5, 2026
Filed
Jun 8, 2026
Kelly Michael Aaron Director
Award
Calculated transaction value
$0 75,000 shares @ $0
Traded
Jun 5, 2026
Filed
Jun 8, 2026
Marrazzo Jeffrey D Director
Award
Calculated transaction value
$0 75,000 shares @ $0
Traded
Jun 5, 2026
Filed
Jun 8, 2026
Chung Wendy Director
Award
Calculated transaction value
$0 75,000 shares @ $0
Traded
Jun 5, 2026
Filed
Jun 8, 2026